These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Martin-Rendon E, Sweeney D, Lu F, Girdlestone J, Navarrete C, Watt SM. Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828 [Abstract] [Full Text] [Related]
3. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Larghero J, Farge D, Braccini A, Lecourt S, Scherberich A, Foïs E, Verrecchia F, Daikeler T, Gluckman E, Tyndall A, Bocelli-Tyndall C. Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552 [Abstract] [Full Text] [Related]
4. Characterization of EGFP-labeled mesenchymal stem cells and redistribution of allogeneic cells after subcutaneous implantation. Duan X, Yang L, Dong S, Xin R, Chen G, Guo L. Arch Orthop Trauma Surg; 2008 Jul; 128(7):751-9. PubMed ID: 18265994 [Abstract] [Full Text] [Related]
5. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation. Prigozhina TB, Khitrin S, Elkin G, Eizik O, Morecki S, Slavin S. Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727 [Abstract] [Full Text] [Related]
6. In utero transplantation of human bone marrow-derived multipotent mesenchymal stem cells in mice. Chou SH, Kuo TK, Liu M, Lee OK. J Orthop Res; 2006 Mar; 24(3):301-12. PubMed ID: 16482576 [Abstract] [Full Text] [Related]
7. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Nimura A, Muneta T, Koga H, Mochizuki T, Suzuki K, Makino H, Umezawa A, Sekiya I. Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254 [Abstract] [Full Text] [Related]
8. Mesenchymal stem cells: heading into the clinic. Koç ON, Lazarus HM. Bone Marrow Transplant; 2001 Feb; 27(3):235-9. PubMed ID: 11277170 [Abstract] [Full Text] [Related]
9. Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration. Smiler D, Soltan M, Albitar M. Implant Dent; 2008 Sep; 17(3):236-47. PubMed ID: 18784524 [Abstract] [Full Text] [Related]
10. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Le Blanc K, Ringdén O. Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285 [Abstract] [Full Text] [Related]
12. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR, Moseley AB, Bacigalupo A. Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293 [Abstract] [Full Text] [Related]
13. Murine bone marrow stromal cells sustain in vivo the survival of hematopoietic stem cells and the granulopoietic differentiation of more mature progenitors. Hubin F, Humblet C, Belaid Z, Lambert C, Boniver J, Thiry A, Defresne MP. Stem Cells; 2005 May; 23(10):1626-33. PubMed ID: 16293584 [Abstract] [Full Text] [Related]
14. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration. Dennis JE, Esterly K, Awadallah A, Parrish CR, Poynter GM, Goltry KL. Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167 [Abstract] [Full Text] [Related]
15. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Villaron EM, Almeida J, López-Holgado N, Alcoceba M, Sánchez-Abarca LI, Sanchez-Guijo FM, Alberca M, Pérez-Simon JA, San Miguel JF, Del Cañizo MC. Haematologica; 2004 Dec; 89(12):1421-7. PubMed ID: 15590390 [Abstract] [Full Text] [Related]
16. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. Chapel A, Bertho JM, Bensidhoum M, Fouillard L, Young RG, Frick J, Demarquay C, Cuvelier F, Mathieu E, Trompier F, Dudoignon N, Germain C, Mazurier C, Aigueperse J, Borneman J, Gorin NC, Gourmelon P, Thierry D. J Gene Med; 2003 Dec; 5(12):1028-38. PubMed ID: 14661178 [Abstract] [Full Text] [Related]
17. A Stro-1(+) human universal stromal feeder layer to expand/maintain human bone marrow hematopoietic stem/progenitor cells in a serum-free culture system. Gonçalves R, Lobato da Silva C, Cabral JM, Zanjani ED, Almeida-Porada G. Exp Hematol; 2006 Oct; 34(10):1353-9. PubMed ID: 16982328 [Abstract] [Full Text] [Related]
18. [Mesenchymal stem cells. Potential use in cell and gene therapy of bone loss caused by aging and osteoporosis]. Justesen J, Stenderup K, Kassem MS. Ugeskr Laeger; 2001 Oct 01; 163(40):5491-5. PubMed ID: 11601113 [Abstract] [Full Text] [Related]
19. Trafficking and differentiation of mesenchymal stem cells. Liu ZJ, Zhuge Y, Velazquez OC. J Cell Biochem; 2009 Apr 15; 106(6):984-91. PubMed ID: 19229871 [Abstract] [Full Text] [Related]
20. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Koç ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W. Bone Marrow Transplant; 2002 Aug 15; 30(4):215-22. PubMed ID: 12203137 [Abstract] [Full Text] [Related] Page: [Next] [New Search]